Similarly, comparisons between COVID-19 survivors (Groups A, B, and C) and non-survivors (Group D) revealed a significantly lower expression of PD-1 on CD4+ T cells (p = 0.007) in survivors. This evidence concerns the gene CD4 and COVID-19.